Carcinoid syndrome epidemiology and demographics

Carcinoid syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Carcinoid Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Carcinoid syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Carcinoid syndrome epidemiology and demographics
CDC on Carcinoid syndrome epidemiology and demographics
Carcinoid syndrome epidemiology and demographics in the news
Blogs on Carcinoid syndrome epidemiology and demographics
Directions to Hospitals Treating Carcinoid syndrome
Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide.

Epidemiology and Demographics

• Carcinoid syndrome is quite rare with a disease prevalence of 15 cases per 1,000,000 people.
• The age-adjusted incidence of carcinoid tumors worldwide is approximately 2 per 100,000 persons.
• The average age at diagnosis is 61.4 years.
• Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
• Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.